Q0155 Dronabinol (syndros) 0.1 milligrams
Also known as: Syndros, dronabinol, THC synthetic
Dronabinol (Syndros) 0.1 milligram oral liquid formulation, a synthetic cannabinoid used for nausea, vomiting, and appetite stimulation.
In Plain Language
appetite stimulant; nausea medication
Clinical Context
Used in cancer chemotherapy-induced nausea/vomiting and appetite stimulation in HIV/AIDS-related cachexia. Requires careful monitoring for psychiatric side effects and drug interactions.
RVU Information
CPT Q0155 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Q-codes are temporary HCPCS codes used when no permanent code exists. Coverage and reimbursement vary by payer and region. Document the clinical indication and medical necessity. These codes may be replaced by permanent codes in future HCPCS updates.
Specialties
Frequently Asked Questions
What is CPT code Q0155?
CPT Q0155 (Dronabinol (syndros) 0.1 milligrams) is a Q Codes code. Dronabinol (Syndros) 0.1 milligram oral liquid formulation, a synthetic cannabinoid used for nausea, vomiting, and appetite stimulation.
Is Q0155 covered by insurance?
Q0155 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Used in cancer chemotherapy-induced nausea/vomiting and appetite stimulation in HIV/AIDS-related cachexia. Requires careful monitoring for psychiatric side effects and drug interactions.
When is CPT Q0155 used?
Used in cancer chemotherapy-induced nausea/vomiting and appetite stimulation in HIV/AIDS-related cachexia. Requires careful monitoring for psychiatric side effects and drug interactions.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.